Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Frauger

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Therapie|July 28, 2018
[Interest of take-home naloxone for opioid overdose]Elisabeth Frauger, Farid Kheloufi, Quentin Boucherie, et al.
Fundamental & Clinical Pharmacology|January 8, 2011
Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicatorFrank Rouby, Vincent Pradel, Elisabeth Frauger, et al.
Therapie|October 25, 2017
Methylphenidate: Gender trends in adult and pediatric populations over a 7year periodCarole Ehrhardt, Quentin Boucherie, Vanessa Pauly, et al.
Annales De Medecine Interne|August 12, 2003
[High-dose buprenorphine prescription in southern France from 1999 to 2001]Julien Mancini, Xavier Thirion, Alain Masut, et al.
Therapie|July 10, 2016
[Not Available]Elisabeth Frauger, Caroline Vigneau, Véronica Orléans, et al.
Fundamental & Clinical Pharmacology|November 17, 2010
Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) networkElisabeth Frauger, Vanessa Pauly, Vincent Pradel, et al.
Therapie|April 3, 2004
[Misuse of trihexyphenidyl (Artane, Parkinane): recent trends]Elisabeth Frauger, Xavier Thirion, Charles Chanut, et al.
Therapie|March 20, 2025
[Prevention of opioid misuse and overdose risk and distribution of naloxone: Current practices, needs and prospects among dispensing pharmacists]Armelle Chan Soc Foh, Salim Mezaache, Franck Turlure, et al.
Substance Use & Misuse|September 13, 2016
Three Complementary Approaches to Characterize Buprenorphine MisuseCéline Eiden, Erika Nogue, Caroline Diot, et al.
Pharmacoepidemiology and Drug Safety|December 2, 2008
Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphineVincent Pradel, Elisabeth Frauger, Xavier Thirion, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Therapie|July 28, 2018
[Interest of take-home naloxone for opioid overdose]Elisabeth Frauger, Farid Kheloufi, Quentin Boucherie, et al.
Fundamental & Clinical Pharmacology|January 8, 2011
Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicatorFrank Rouby, Vincent Pradel, Elisabeth Frauger, et al.
Therapie|October 25, 2017
Methylphenidate: Gender trends in adult and pediatric populations over a 7year periodCarole Ehrhardt, Quentin Boucherie, Vanessa Pauly, et al.
Annales De Medecine Interne|August 12, 2003
[High-dose buprenorphine prescription in southern France from 1999 to 2001]Julien Mancini, Xavier Thirion, Alain Masut, et al.
Therapie|July 10, 2016
[Not Available]Elisabeth Frauger, Caroline Vigneau, Véronica Orléans, et al.
Fundamental & Clinical Pharmacology|November 17, 2010
Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) networkElisabeth Frauger, Vanessa Pauly, Vincent Pradel, et al.
Therapie|April 3, 2004
[Misuse of trihexyphenidyl (Artane, Parkinane): recent trends]Elisabeth Frauger, Xavier Thirion, Charles Chanut, et al.
Therapie|March 20, 2025
[Prevention of opioid misuse and overdose risk and distribution of naloxone: Current practices, needs and prospects among dispensing pharmacists]Armelle Chan Soc Foh, Salim Mezaache, Franck Turlure, et al.
Substance Use & Misuse|September 13, 2016
Three Complementary Approaches to Characterize Buprenorphine MisuseCéline Eiden, Erika Nogue, Caroline Diot, et al.
Pharmacoepidemiology and Drug Safety|December 2, 2008
Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphineVincent Pradel, Elisabeth Frauger, Xavier Thirion, et al.
Pageof 6